GLS and urinary bladder carcinoma: Recent studies found that lincRNA-p21 can inhibit bladder cancer proliferation by negatively regulating glutaminase, glutamate, and α-ketoglutarate expression (Benitez et al., 2021; Scholda et al., 2023).